Skip to main content

IMMUCELL CORP /DE/

جودة البيانات: 100%
ICCC
Nasdaq Manufacturing Chemicals
KWD 7.08
▼ KWD 0.11 (-1.53%)
القيمة السوقية: 65.05 M
السعر
KWD 7.19
القيمة السوقية
65.05 M
نطاق اليوم
نطاق 52 أسبوعًا
حجم التداول
فتح —
متوسط 50 يوم / 200 يوم
متوسط 50 يوم / 200 يوم

Quick Summary

النقاط الرئيسية

Debt/Equity of 0.32 — conservative balance sheet
Generating 1.22 M in free cash flow
Capital efficient — spends only 4.52% of revenue on capex
ROIC of 3.10% — low return on invested capital

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)4.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-3.49%
أعلى من متوسط القطاع (-53.53%)
ROIC3.10%
Net Margin-3.76%
Op. Margin5.97%

الأمان

Debt / Equity
0.32
أعلى من متوسط القطاع (0.31)
Current Ratio4.21
Interest Coverage3.34

التقييم

PE (TTM)
-62.54
أقل من متوسط القطاع (-1.48)
P/B Ratio2.18
EV/EBITDA15.94
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1366 نظير)
المقياس السهم وسيط القطاع
P/E -62.5 -1.5
P/B 2.2 1.6
ROE % -3.5 -53.5
Net Margin % -3.8 -41.5
Rev Growth 5Y % 1.8
D/E 0.3 0.3

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

مفاجآت الأرباح

آخر 4 أرباع
الربع EPS المقدر EPS الفعلي المفاجأة
Q42020 -KWD 0.04 KWD 0.03 +175.0%
Q32020 -KWD 0.08 -KWD 0.04 +50.0%
Q22020 -KWD 0.10 -KWD 0.11 -10.0%
Q12020 N/A -KWD 0.02

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4.34% Revenue Growth (3Y) 25.79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 27.64 M Net Income (TTM) -1.04 M
ROE -3.49% ROA -2.25%
Gross Margin 41.40% Operating Margin 5.97%
Net Margin -3.76% Free Cash Flow (TTM) 1.22 M
ROIC 3.10% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.32 Current Ratio 4.21
Interest Coverage 3.34 Asset Turnover 0.60
Working Capital 12.83 M Tangible Book Value 29.70 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -62.54 Forward P/E N/A
P/B Ratio 2.18 P/S Ratio 2.35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 15.94 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1.88%
Market Cap 65.05 M Enterprise Value 70.65 M
Per Share
EPS (Diluted TTM) -0.12 Revenue / Share 3.06
FCF / Share 0.14 OCF / Share 0.27
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4.52% FCF Conversion -117.77%
SBC-Adj. FCF 955,206 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 27.64 M 26.49 M 17.47 M
Net Income -1.04 M -2.16 M -5.77 M -2.49 M -78,292.0
EPS (Diluted) -0.12 -0.26 -0.75 -0.32 -0.01
Gross Profit 11.45 M 7.94 M 3.87 M 7.65 M 8.66 M
Operating Income 1.65 M -1.64 M -5.75 M -2.30 M 257,385.0
EBITDA
R&D Expenses 3.04 M 3.90 M 4.39 M 4.49 M 4.17 M
SG&A Expenses
D&A 2.78 M
Interest Expense 493,384.0 475,598.0 348,536.0
Income Tax 11,570.0 10,056.0 4,627.0 7,672.0 9,165.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 42.53 M 45.10 M 43.81 M 44.86 M 44.47 M
Total Liabilities 15.48 M 17.58 M 18.82 M 14.48 M 11.89 M
Shareholders' Equity 27.06 M 27.52 M 24.99 M 30.38 M 32.58 M
Total Debt 9.10 M 10.43 M 10.23 M 812,207.0
Cash & Equivalents 3.81 M 978,741.0 5.79 M 10.19 M
Current Assets 16.94 M 15.04 M 13.99 M 16.26 M
Current Liabilities 3.98 M 4.41 M 4.20 M 3.07 M 2.53 M